iotrolan has been researched along with Granuloma in 1 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Granuloma: A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.
Excerpt | Relevance | Reference |
---|---|---|
"Iotrolan, which is a water-soluble and nonionic dimeric contrast medium, has potential greater safety for use in HSG than Lipiodol." | 1.29 | Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol. ( Azuma, H; Ishida, K; Iwai, K; Miyamoto, Y; Miyazawa, T; Tsujimoto, T; Uchimoto, R, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyamoto, Y | 1 |
Tsujimoto, T | 1 |
Iwai, K | 1 |
Ishida, K | 1 |
Uchimoto, R | 1 |
Miyazawa, T | 1 |
Azuma, H | 1 |
1 other study available for iotrolan and Granuloma
Article | Year |
---|---|
Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
Topics: Abdomen; Animals; Ascitic Fluid; Contrast Media; Feces; Female; Granuloma; Half-Life; Hysterosalping | 1995 |